Graphite Bio Inc. (GRPH)

Healthcare | Biotechnology & Pharma Research

52 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Annual
Quarterly

Please wait...

About The Company

Business: Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States.

IPO Date: 25-Jun-2021

Pres, CEO & Director: Dr. Joshua Lehrer-Graiwer FACC, M.D.

Academic Founder & Director: Dr. Matthew Porteus M.D., Ph.D.

Listing: NASDAQ: GRPH

Country: United States

Headquarters: South San Francisco, CA

Website: https://www.graphitebio.com

Key Facts

Market cap: $166.37 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-76.89 Mln

Cash: $339.18 Mln

Total Debt: $10.18 Mln

Insider's Holding: 9.55%

Liquidity: Low

52 Week range: $2.07 - 32.49

Shares outstanding: 57,970,100

Time Period	Graphite Bio (GRPH)	S&P BSE Sensex	S&P Small-Cap 600
YTD	-77.35	-8.99	-19.23
1 month	20.30	-3.40	-9.35
3 months	-46.18	-8.50	-16.59
1 Year	-89.80	0.89	-17.36
3 Years	--	10.41	5.90
5 Years	--	11.43	5.77
10 Years	--	11.77	9.78

As on 30-Jun-2022

Get Started

Start your investing journey with confidence

Investing for Growth

Get profitable mutual fund ideas to create wealth and achieve your financial goals.

Investing for Income

The Value Research way of earning dependable income from your investments.

Tax Planning

Looking to save tax? Here's how to make the most of your Section 80C limit

Insurance

Follow the comprehensive roadmap if you are planning to buy a insurance policy for your family.

Get Started

Designed especially for the new investors, now you can learn and understand everything about mutual funds and investing in general.

VR Helpline

Archive of helpline videos and value research customer care that guides investors on personal finance decisions, mutual funds and investments.

Investors' Hangout

Investors Hangout is a popular financial advice webinar series hosted by Dhirendra Kumar.

Value Investing

Get best advice on value investing and investment strategy. Professional advice to investors and investment approach. Find complete guide to value investing at Value Research Online.

Graphite Bio Inc. (GRPH)

52 Stocks to buy right now

About The Company

Business: Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States.

IPO Date: 25-Jun-2021

Pres, CEO & Director: Dr. Joshua Lehrer-Graiwer FACC, M.D.

Academic Founder & Director: Dr. Matthew Porteus M.D., Ph.D.

Listing: NASDAQ: GRPH

Country: United States

Headquarters: South San Francisco, CA

Website: https://www.graphitebio.com

Key Facts

Market cap: $166.37 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-76.89 Mln

Cash: $339.18 Mln

Total Debt: $10.18 Mln

Insider's Holding: 9.55%

Liquidity: Low

52 Week range: $2.07 - 32.49

Shares outstanding: 57,970,100

Stock Performance

My Investments

My Watchlist

Get Started

Start your investing journey with confidence

Investing for Growth

Get profitable mutual fund ideas to create wealth and achieve your financial goals.

Investing for Income

The Value Research way of earning dependable income from your investments.

Tax Planning

Looking to save tax? Here's how to make the most of your Section 80C limit

Insurance

Follow the comprehensive roadmap if you are planning to buy a insurance policy for your family.

Quick Links

Fund Screeners Go to Fund Screener

Value Research Premium More Features

Quick Links

Stock Screeners

Get Started

Designed especially for the new investors, now you can learn and understand everything about mutual funds and investing in general.

VR Helpline

Archive of helpline videos and value research customer care that guides investors on personal finance decisions, mutual funds and investments.

Investors' Hangout

Investors Hangout is a popular financial advice webinar series hosted by Dhirendra Kumar.

Value Investing

Get best advice on value investing and investment strategy. Professional advice to investors and investment approach. Find complete guide to value investing at Value Research Online.

Graphite Bio Inc. (GRPH)

52 Stocks to buy right now

About The Company

Business: Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States.

IPO Date: 25-Jun-2021

Pres, CEO & Director: Dr. Joshua Lehrer-Graiwer FACC, M.D.

Academic Founder & Director: Dr. Matthew Porteus M.D., Ph.D.

Listing: NASDAQ: GRPH

Country: United States

Headquarters: South San Francisco, CA

Website: https://www.graphitebio.com

Key Facts

Market cap: $166.37 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-76.89 Mln

Cash: $339.18 Mln

Total Debt: $10.18 Mln

Insider's Holding: 9.55%

Liquidity: Low

52 Week range: $2.07 - 32.49

Shares outstanding: 57,970,100

Stock Performance